Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis.
about
Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapyVascular endothelial growth factor-B in physiology and diseaseTargeted inhibition of VEGF receptor 2: an update on ramucirumab.Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes.Resveratrol plays dual roles in pancreatic cancer cells.VEGF-B promotes cancer metastasis through a VEGF-A-independent mechanism and serves as a marker of poor prognosis for cancer patientsCombining the multitargeted tyrosine kinase inhibitor vandetanib with the antiestrogen fulvestrant enhances its antitumor effect in non-small cell lung cancerTumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs.Promoter CpG island methylation of genes in key cancer pathways associates with clinical outcome in high-grade serous ovarian cancer.Differential expression of vascular endothelial growth factor isoforms and receptor subtypes in the infarcted heart.The VEGF signaling pathway in cancer: the road ahead.An expression signature of the angiogenic response in gastrointestinal neuroendocrine tumours: correlation with tumour phenotype and survival outcomes.VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.Endothelium as a gatekeeper of fatty acid transport.Reduced angiogenic gene expression in morbillivirus-triggered oncolysis in a translational model for histiocytic sarcoma.Metformin potentiates anti-tumor effect of resveratrol on pancreatic cancer by down-regulation of VEGF-B signaling pathway.Recent developments in treatment stratification for metastatic breast cancer.Sunitinib for advanced pancreatic neuroendocrine tumors.The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.Downregulation of receptor for activated C-kinase 1 (RACK1) suppresses tumor growth by inhibiting tumor cell proliferation and tumor-associated angiogenesis.VEGF receptor-2-specific signaling mediated by VEGF-E induces hemangioma-like lesions in normal and in malignant tissue.RNA interference-mediated silencing of VEGF and bFGF suppresses endostatin secretion in pancreatic carcinoma cellsVascular endothelial growth factor-B: Impact on physiology and pathology.The Rip1Tag2 Transgenic Mouse Model.
P2860
Q26853604-0D17BF8A-7434-485D-B62F-7041E706D91BQ27003400-7C375463-940D-4DDF-A93F-AD3D8389AD40Q34040956-A6745F64-8B65-4407-BB8D-9495429B9903Q34302721-5B368C1B-550C-48BF-B733-F6D4928AEBFDQ35113534-3608258F-08B4-4C0C-8F4B-E28D6F2E3E8EQ35698934-E8A83E29-4C39-4AEA-847D-31D4C274943FQ35784523-707B9F94-41A4-4429-AC98-ACC5192FA5EFQ36535215-2CC9680B-1C90-4696-96B9-E702B2D8D620Q37021075-2E927073-52AC-49F6-B2FF-063AD4EAF669Q37022081-9E8F6487-340B-452E-81DD-C39C1AE53D2DQ37354128-E0B14637-C08E-4019-A9FD-C6D7AD3F461EQ37459597-B0664143-16EC-497E-BB38-E7750A357C34Q37469455-F57D49B8-F01A-4D88-932E-AE452B8A14A1Q37624930-F3BDB1D2-4CE4-49A7-9B73-18E1F1CA8BC2Q37693344-08C17774-C341-4697-91A2-A397BFA209B9Q37708932-82693DD7-B865-491C-ADA7-CAEFFF22D6FFQ37950515-B640C711-DD64-43B5-8CC4-6F601ADBA32EQ37960905-41BC93D8-8680-4353-A606-5FC2BBF20790Q39131192-D7B04D40-EC24-4BBC-AD4E-1A45D28DD9B6Q39489122-246A715B-A4B0-4F28-A1BE-5CBDB6086994Q40821361-CE9C7E09-2104-42F4-ABFE-2145E896D138Q41880317-BC6ABFCC-85C4-4F47-99C6-7FD058AD74D4Q47450318-36E64FAF-3A1C-430E-9907-A67C10AB16E7Q47988392-782321BA-3F6D-4D94-AC06-482FE70145F0
P2860
Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Suppressive effects of vascula ...... neuroendocrine tumorigenesis.
@ast
Suppressive effects of vascula ...... neuroendocrine tumorigenesis.
@en
type
label
Suppressive effects of vascula ...... neuroendocrine tumorigenesis.
@ast
Suppressive effects of vascula ...... neuroendocrine tumorigenesis.
@en
prefLabel
Suppressive effects of vascula ...... neuroendocrine tumorigenesis.
@ast
Suppressive effects of vascula ...... neuroendocrine tumorigenesis.
@en
P2093
P2860
P50
P1433
P1476
Suppressive effects of vascula ...... neuroendocrine tumorigenesis.
@en
P2093
Annelie Falkevall
Gerhard Christofori
Imke Albrecht
Karin Strittmatter
Kristian Pietras
Lucie Kopfstein
Pascal Lorentz
Tibor Schomber
Ulf Eriksson
P2860
P304
P356
10.1371/JOURNAL.PONE.0014109
P407
P577
2010-11-24T00:00:00Z